RYTM — RHYTHM PHARMACEUTICALS, INC.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1649904 ·
Last close
$116.61
Market Cap
$8.08B
52W High
$122.20
52W Low
$74.50
ADV30
1,522,794
Next earnings
2026-11-03

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 92,128,000 79,962,000 -39,270,000 -41,369,000 443,132,000 39,981,000 241,589,000
Jun 2026 71,255,000 62,324,000 -48,552,000 -49,298,000 437,266,000 65,614,000 219,965,000
Mar 2026 60,112,000 52,955,000 -52,361,000 -55,639,000 442,316,000 62,137,000 204,700,000
Dec 2025 57,253,000 52,451,000 -47,063,000 -47,505,000 480,196,000 54,301,000 210,170,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-81,788,000
Investing CF
$85,306,000
Financing CF
$-15,761,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.90
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,498,183,000
Inventory
$31,187,000
Receivables
$39,120,000
ST Investments
$280,963,000
EBIT TTM
$-174,010,000
Pretax Income TTM
$-192,243,000
Interest Exp TTM
$18,233,000
Analysts
17

Yahoo Snapshot (yfinance, live)

Total Revenue
$280,747,008
EBITDA
$-186,227,008
Free Cash Flow
$-17,757,876
Enterprise Value
$7,683,288,064
Total Cash
$320,944,000
Total Debt
$106,181,000
Shares Out
69,330,906
Trailing EPS
$-2.91
Book Value
$1.27
ROE
-78.0%
ROA
-24.6%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 189,757,000 -192,016,000 -196,539,000 480,196,000 210,170,000 270,026,000 -115,675,000
Dec 2024 130,126,000 -265,503,000 -260,602,000 392,273,000 227,724,000 164,549,000 -113,879,000
Dec 2023 77,428,000 -184,357,000 -184,678,000 332,745,000 162,986,000 169,759,000 -136,157,000
Dec 2022 23,638,000 -179,157,000 -181,119,000 382,481,000 118,219,000 264,262,000 -173,428,000
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
$239,918,000
NetIncome TTM
$-205,346,000
OpCashFlow TTM
—
Assets (Latest)
$437,266,000
Forward EPS
$-1.30

Max Pain — expiry 2027-01-15

max pain strike: $90.00 · spot: $119.04 · call oi: 1,755 · put oi: 351

Peers — same industry

TickerNameMarket CapLastDaily %
PTGX Protagonist Therapeutics, Inc $8.07B $124.67 —
CORT CORCEPT THERAPEUTICS INC $7.67B $70.07 —
PRAX Praxis Precision Medicines, Inc. $8.53B $305.06 —
SMMT Summit Therapeutics Inc. $8.53B $10.67 —
ALKS Alkermes plc. $7.64B $45.45 —

News headlines (Yahoo Finance, 1h cache)

Rhythm Stock Is Up 32%. Is One Drug Enough?
2026-11-18 11:32 · Yahoo
Rhythm Pharmaceuticals Says Rare Obesity Drug Delivers Sustained Two-Year BMI Reductions
2026-11-17 15:11 · Yahoo
Rhythm Pharmaceuticals Announces Presentation of New Data at ObesityWeek® 2026
2026-11-16 21:00 · Yahoo
RYTM Stock Clocks Best Day In Nearly 16 Months On AstraZeneca $10B Bid Report
2026-11-04 22:20 · Yahoo
Rhythm Pharmaceuticals stock surges 28% on AstraZeneca bid report
2026-11-04 21:53 · Yahoo
Could Rhythm Pharmaceuticals (RYTM) Be Too Pricey After Recent Funding?
2026-11-04 18:16 · Yahoo
Rhythm Pharmaceuticals Stock In Focus After Earnings Beat And $750 Million Financing
2026-11-04 14:16 · Yahoo
Rhythm Pharmaceuticals Announces NICE Guidance for IMCIVREE® (Setmelanotide) Updated to Include Adults Living with Bardet-Biedl Syndrome
2026-11-04 13:00 · Yahoo
What Does Rhythm Pharmaceuticals (RYTM) Mean With A $750 Million Financing Deal?
2026-11-04 10:20 · Yahoo
Rhythm Pharmaceuticals (RYTM) Dropped, So What Is Behind The Fresh Attention?
2026-11-04 07:10 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.